DREDGECAP
NASDAQ·Pharmaceutical Preparations

ARWRARROWHEAD PHARMACEUTICALS, INC.

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) has a auditor change flag.

Last filing: filing·May 7, 2026EDGAR ↗

ARWR Cash Runway

Months-of-runway analysis for ARWR, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on ARWR

Share-count dilution →
Dilution is the natural counterpart to runway burn.
Going-concern history →
Auditor + management language across filings.